Lupin Limited has informed the Exchange regarding a press release dated September 17, 2025, titled "Lupin Receives Approval from U.S. FDA for Lenalidomide Capsules".
Lupin Limited has informed the Exchange regarding a press release dated September 17, 2025, titled "Lupin Receives Approval from U.S. FDA for Lenalidomide Capsules".